Biotech Fund Superstring Capital Opens $6 Million Position in Vir Biotechnology
Superstring Capital Management disclosed a new position in Vir Biotechnology, acquiring shares valued at approximately $5.82 million during the first quarter of 2026. The fund's investment reflects confidence amid a significant stock rally for Vir, which has seen its share price rise by 99% over the past year.
Tickers: $VIR